Clinical Trial Update: Ixabepilone in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial of ixabepilone in metastatic prostate cancer has completed, and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ixabepilone (ixabepilone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-12-27